Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
J Am Acad Dermatol
; 69(3): 343.e1-11; quiz 355-6, 2013 Sep.
Article
em En
| MEDLINE
| ID: mdl-23957985
Palavras-chave
CBCL; CHOP; DLBCL; EORTC-CLG; European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Group; FISH; MALT; NCCN; National Comprehensive Cancer Network; PCBCL; PCDLBCL-LT; PCFCL; PCMZL; R-CHOP; cutaneous B-cell lymphoma; cyclophosphamide, doxorubicin, onvocin/vincristine, and prednisone; cyclophosphamide, doxorubicin, onvocin/vincristine, and prednisone with rituximab; diffuse large B-cell lymphoma; fluorescence in situ hybridization; lymphoma; mucosa-associated lymphoid tissue; primary cutaneous B-cell lymphoma; primary cutaneous diffuse large B-cell lymphoma; primary cutaneous diffuse large B-cell lymphoma, leg type; primary cutaneous follicle center lymphoma; primary cutaneous marginal zone lymphoma; rituximab; therapy
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Cutâneas
/
Linfoma Folicular
/
Linfoma Difuso de Grandes Células B
/
Linfoma de Zona Marginal Tipo Células B
Limite:
Humans
Idioma:
En
Revista:
J Am Acad Dermatol
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Estados Unidos